AIG
CUE icon

American International Group’s Cue Biopharma CUE Stock Holding History

American International Group’s Portfolio CUE Stock Details CUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-591
Closed -$33.5K – 677
2024
Q1 		$33.5K Sell
591
-5
-0.8% -$353 ﹤0.01% 2860
2023
Q4 		$47.2K Buy
596
+21
+4% +$1.5K ﹤0.01% 2829
2023
Q3 		$39.7K Buy
575
+20
+4% +$1.95K ﹤0.01% 2877
2023
Q2 		$60.7K Buy
+555
New +$65.2K ﹤0.01% 2829
2022
Q2 		– Sell
-509
Closed -$75K – 3131
2022
Q1 		$75K Sell
509
-36
-7% -$7.63K ﹤0.01% 2696
2021
Q4 		$185K Sell
545
-16
-3% -$6.19K ﹤0.01% 2420
2021
Q3 		$245K Buy
561
+5
+0.9% +$1.74K ﹤0.01% 2304
2021
Q2 		$194 Sell
556
-18
-3% -$6.98K ﹤0.01% 2521
2021
Q1 		$210 Buy
574
+2
+0.3% +$823 ﹤0.01% 2338
2020
Q4 		$215 Sell
572
-2
-0.3% -$799 ﹤0.01% 2249
2020
Q3 		$259K Buy
574
+9
+2% +$5.19K ﹤0.01% 1979
2020
Q2 		$416K Buy
565
+171
+43% +$124K ﹤0.01% 1692
2020
Q1 		$168K Sell
394
-23
-6% -$11.2K ﹤0.01% 1992
2019
Q4 		$198K Buy
417
+4
+1% +$1.26K ﹤0.01% 2226
2019
Q3 		$104K Buy
413
+31
+8% +$7.45K ﹤0.01% 2581
2019
Q2 		$103K Sell
382
-4
-1% -$995 ﹤0.01% 2662
2019
Q1 		$90K Sell
386
-2
-0.5% -$380 ﹤0.01% 2667
2018
Q4 		$55K Sell
388
-3
-0.8% -$544 ﹤0.01% 2852
2018
Q3 		$106K Buy
391
+7
+2% +$2.02K ﹤0.01% 2810
2018
Q2 		$137K Buy
384
+194
+102% +$77.1K ﹤0.01% 2602
2018
Q1 		$80K Buy
+190
New +$86.6K ﹤0.01% 2762

Other funds holding CUE

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RSWM
Robertson Stephens Wealth Management San Francisco, California $3.57B AUM 28.36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
GLA
Good Life Advisors Reading, Pennsylvania $1.6B AUM 15.83% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

American International Group's CUE Position: Q2 2024 in Review

American International Group sold out of Cue Biopharma (CUE) in Q2 2024, closing a stake of 591 shares — an estimated $33.5K sold.

American International Group first reported a position in CUE in Q1 2018 and held it in 21 quarters. The position peaked at $416K in Q2 2020. 75 funds tracked by Wall St. Rank hold CUE as of Q2 2024.

  • American International Group reported no remaining Cue Biopharma position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 591 Cue Biopharma shares in Q2 2024, an estimated $33.5K.
  • American International Group first reported a position in Cue Biopharma in Q1 2018 and held it in 21 quarters.
  • American International Group's Cue Biopharma position peaked at $416K in Q2 2020.
  • 75 funds tracked by Wall St. Rank held Cue Biopharma as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.